This brand name is authorized in New Zealand.
The drug ACNEDERM contains one active pharmaceutical ingredient (API):
1
|
UNII
F2VW3D43YT - AZELAIC ACID
|
|
Azelaic Acid is a naturally occurring dicarboxylic acid. Azelaic acid possesses antibacterial, keratolytic, comedolytic, and anti-oxidant activity. Azelaic acid is bactericidal against Proprionibacterium acnes and Staphylococcus epidermidis due to its inhibitory effect on the synthesis of microbial cellular proteins. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| D10AX03 | Azelaic acid | D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AX Other anti-acne preparations for topical use |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NZ | Medicines and Medical Devices Safety Authority | 9860 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.